Results 181 to 190 of about 2,748,395 (254)

Prolonged Somatostatin Receptor 2 Antagonism Enhances Glucagon Response to Hypoglycemia in Male Diabetic Rats. [PDF]

open access: yesEndocrinology
D'Souza NC   +9 more
europepmc   +1 more source

Glucagonoma of the pancreas: diagnostic approach and therapeutic algorithm for a rare nosological entity. [PDF]

open access: yesAnn Gastroenterol
Mastoraki A   +13 more
europepmc   +1 more source

Beyond Diabetes: A Review of Emerging Indications for Glucagon-Like Peptide-1 Receptor Agonists. [PDF]

open access: yesRev Cardiovasc Med
West L   +6 more
europepmc   +1 more source

Congenital Hyperinsulinemic Hypoglycemia With a New HADH Mutation and Pancreatic Overexpression of GLP-1 Receptors.

open access: yesJ Clin Endocrinol Metab
Widmer A   +9 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Glucagon and glucagon-like peptide receptors as drug targets.

Current Pharmaceutical Design, 2006
Glucagon and the glucagon-like peptides are derived from a common proglucagon precursor, and regulate energy homeostasis through interaction with a family of distinct G protein coupled receptors. Three proglucagon-derived peptides, glucagon, GLP-1, and GLP-2, play important roles in energy intake, absorption, and disposal, as elucidated through studies
J. Estall, D. Drucker
semanticscholar   +3 more sources

Home - About - Disclaimer - Privacy